Category: cancer immunotherapy
Immunai raises $60M as it expands from improving immune therapies to discovering new ones, too
Just three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million. Despite its youth, Immunai has already established the largest database in the world for single cell immunity characteristics, and it has already used its machine…
Read More
Immunai wants to map the entire immune system and raised $20 million in seed funding to do it
For the past two years the founding team of Immunai had been working stealthily to develop a new technology to map the immune system of any patient. Founded by Noam Solomon, a Harvard and MIT-educated postdoctoral researcher, and former Palantir engineer, Luis Voloch, Immunai was born from the two men’s…
Read More